dieulafoy's lesion: a case report · 2017. 1. 11. · dieulafoy’s lesion: a case report 279...

2
Revista de Gastroenterología de México. 2015;80(4):278---279 www.elsevier.es/rgmx REVISTA DE GASTROENTEROLOGIA DE MEXICO ´ ´ CLINICAL IMAGE Dieulafoy’s lesion: A case report Lesión de Dieulafoy: reporte de un caso S. Rodríguez-Jacobo a,, J.S. Jacobo-Karam b a Facultad de Medicina, Universidad de Monterrey, Durango, Durango, Mexico b Hospital General 450, Secretaría de Salud Durango, Durango, Durango, Mexico Received 1 April 2015; accepted 1 May 2015 Dieulafoy’s lesion A 26-year-old man suffered from chronic alcoholism and had multiple body tatoos and perforations. Illness began 5 days prior to hospital admission with hematemesis and recurrent melena and he presented with hemodynamic decompensation and shock. The patient stated that he did not take nonsteroidal anti-inflammatory agents or other drugs and he had no signs of peptic acid disease. Physi- cal examination revealed blood pressure of 80/40 mmHg, heart rate 130 min, generalized pallor, diaphoresis, and no hepatopathy stigmata. Laboratory work-up reported: hemoglobin 3.62 mg/dl, MCV 93.2 3 , MCH 34.2 g/dl, leukocytes 7,470 mm 3 , and platelets 151,000 mm 3 . Blood chemistry showed normal serum electrolytes and liver func- tion tests; AcHC, HBsAg, and HIV were negative. Liver ultrasound was normal. Endoscopy revealed Dieulafoy’s lesion in the gastric fundus at 4 cm from the cardia with active bleeding (figs. 1 and 2). Sclerotherapy with polido- canol at 1% was performed and bleeding was controlled (fig. 3). The patient remained asymptomatic and was released one week later with Hb of 9.2 mg/dl. Please cite this article as: Rodríguez-Jacobo S, Jacobo-Karam JS. Lesión de Dieulafoy: reporte de un caso. Revista de Gastroen- terología de México. 2015;80:278---279. Corresponding author. E-mail address: sofi[email protected] (S. Rodríguez-Jacobo). Figure 1 Active bleeding. 2255-534X/© 2015 Asociación Mexicana de Gastroenterología. Published by Masson Doyma México S.A. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). brought to you by CORE View metadata, citation and similar papers at core.ac.uk provided by Elsevier - Publisher Connector

Upload: others

Post on 10-Jun-2021

2 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Dieulafoy's lesion: A case report · 2017. 1. 11. · Dieulafoy’s lesion: A case report 279 Figure 2 Sclerosis of the Dieulafoy’s lesion. Figure 3 Control of bleeding. Ethical

R

C

D

L

S

a

b

R

D

Ah5rdndchnhlctulac(r

Jt

2t

by COREView metadata

her Connector

evista de Gastroenterología de México. 2015;80(4):278---279

www.elsevier.es/rgmx

REVISTA DEGASTROENTEROLOGIA

DE MEXICO´

´

LINICAL IMAGE

ieulafoy’s lesion: A case report�

esión de Dieulafoy: reporte de un caso

. Rodríguez-Jacoboa,∗, J.S. Jacobo-Karamb

Facultad de Medicina, Universidad de Monterrey, Durango, Durango, MexicoHospital General 450, Secretaría de Salud Durango, Durango, Durango, Mexico

brought to you, citation and similar papers at core.ac.uk

provided by Elsevier - Publis

eceived 1 April 2015; accepted 1 May 2015

Figure 1 Active bleeding.

ieulafoy’s lesion

26-year-old man suffered from chronic alcoholism andad multiple body tatoos and perforations. Illness began

days prior to hospital admission with hematemesis andecurrent melena and he presented with hemodynamicecompensation and shock. The patient stated that he didot take nonsteroidal anti-inflammatory agents or otherrugs and he had no signs of peptic acid disease. Physi-al examination revealed blood pressure of 80/40 mmHg,eart rate 130 min, generalized pallor, diaphoresis, ando hepatopathy stigmata. Laboratory work-up reported:emoglobin 3.62 mg/dl, MCV 93.2 �3, MCH 34.2 g/dl,eukocytes 7,470 mm3, and platelets 151,000 mm3. Bloodhemistry showed normal serum electrolytes and liver func-ion tests; AcHC, HBsAg, and HIV were negative. Liverltrasound was normal. Endoscopy revealed Dieulafoy’sesion in the gastric fundus at 4 cm from the cardia withctive bleeding (figs. 1 and 2). Sclerotherapy with polido-anol at 1% was performed and bleeding was controlledfig. 3). The patient remained asymptomatic and waseleased one week later with Hb of 9.2 mg/dl.

� Please cite this article as: Rodríguez-Jacobo S, Jacobo-Karam

S. Lesión de Dieulafoy: reporte de un caso. Revista de Gastroen-erología de México. 2015;80:278---279.∗ Corresponding author.

E-mail address: [email protected] (S. Rodríguez-Jacobo).

255-534X/© 2015 Asociación Mexicana de Gastroenterología. Publishedhe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-n

by Masson Doyma México S.A. This is an open access article underd/4.0/).

Page 2: Dieulafoy's lesion: A case report · 2017. 1. 11. · Dieulafoy’s lesion: A case report 279 Figure 2 Sclerosis of the Dieulafoy’s lesion. Figure 3 Control of bleeding. Ethical

Dieulafoy’s lesion: A case report

Figure 2 Sclerosis of the Dieulafoy’s lesion.

Figure 3 Control of bleeding.

E

Ptf

Dft

Rojp

F

Ns

Conflict of interest

The authors declare that there is no conflict of interest.

279

thical responsibilities

rotection of persons and animals. The authors declarehat no experiments were performed on humans or animalsor this study.

ata confidentiality. The authors declare that they haveollowed the protocols of their work center in relation tohe publication of patient data.

ight to privacy and informed consent. The authors havebtained the informed consent of the patients and/or sub-ects referred to in the article. This document is in theossession of the corresponding author.

inancial disclosure

o financial support was received in relation to thistudy/article.